GB0817809D0 - Agent for treating disease - Google Patents

Agent for treating disease

Info

Publication number
GB0817809D0
GB0817809D0 GB0817809A GB0817809A GB0817809D0 GB 0817809 D0 GB0817809 D0 GB 0817809D0 GB 0817809 A GB0817809 A GB 0817809A GB 0817809 A GB0817809 A GB 0817809A GB 0817809 D0 GB0817809 D0 GB 0817809D0
Authority
GB
United Kingdom
Prior art keywords
agent
treating disease
disease
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0817809A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotest AG
Original Assignee
Biotest AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotest AG filed Critical Biotest AG
Priority to GB0817809A priority Critical patent/GB0817809D0/en
Publication of GB0817809D0 publication Critical patent/GB0817809D0/en
Priority to CA2717812A priority patent/CA2717812A1/en
Priority to EP09720958.9A priority patent/EP2260057B1/en
Priority to BRPI0909179-3A priority patent/BRPI0909179A2/en
Priority to NZ602518A priority patent/NZ602518A/en
Priority to RU2010141822/10A priority patent/RU2540018C2/en
Priority to PCT/EP2009/052810 priority patent/WO2009112502A1/en
Priority to ES09720958.9T priority patent/ES2610327T3/en
Priority to AU2009224690A priority patent/AU2009224690B2/en
Priority to JP2010550182A priority patent/JP5604311B2/en
Priority to CN2009801173185A priority patent/CN102027018A/en
Priority to KR1020107022912A priority patent/KR20100135808A/en
Priority to SG2013034210A priority patent/SG190627A1/en
Priority to MX2010010027A priority patent/MX2010010027A/en
Priority to KR1020117009215A priority patent/KR20110061630A/en
Priority to PL09782400T priority patent/PL2341937T3/en
Priority to NZ603751A priority patent/NZ603751A/en
Priority to ES09782400.7T priority patent/ES2528419T3/en
Priority to DK09782400.7T priority patent/DK2341937T3/en
Priority to SG2013070859A priority patent/SG194362A1/en
Priority to PCT/EP2009/061210 priority patent/WO2010034590A1/en
Priority to EP09782400.7A priority patent/EP2341937B1/en
Priority to SI200931140T priority patent/SI2341937T1/en
Priority to JP2011528278A priority patent/JP2012504110A/en
Priority to PT97824007T priority patent/PT2341937E/en
Priority to AU2009296078A priority patent/AU2009296078B2/en
Priority to RU2011117293/10A priority patent/RU2531548C2/en
Priority to BRPI0919489A priority patent/BRPI0919489A2/en
Priority to CA2738598A priority patent/CA2738598C/en
Priority to MX2011003335A priority patent/MX2011003335A/en
Priority to CN200980143326.7A priority patent/CN102215867B/en
Priority to IL207892A priority patent/IL207892A0/en
Priority to US12/880,768 priority patent/US9550831B2/en
Priority to CR11723A priority patent/CR11723A/en
Priority to CO10127116A priority patent/CO6311008A2/en
Priority to IL211904A priority patent/IL211904A/en
Priority to US13/074,357 priority patent/US20110229465A1/en
Priority to CO11050626A priority patent/CO6361951A2/en
Priority to CR20110226A priority patent/CR20110226A/en
Priority to HK11109118.5A priority patent/HK1154797A1/en
Priority to JP2014011246A priority patent/JP2014101369A/en
Priority to HRP20150238AT priority patent/HRP20150238T1/en
Priority to JP2015097888A priority patent/JP6154847B2/en
Ceased legal-status Critical Current

Links

GB0817809A 2008-03-13 2008-09-29 Agent for treating disease Ceased GB0817809D0 (en)

Priority Applications (43)

Application Number Priority Date Filing Date Title
GB0817809A GB0817809D0 (en) 2008-09-29 2008-09-29 Agent for treating disease
MX2010010027A MX2010010027A (en) 2008-03-13 2009-03-10 Agent for treating disease.
PCT/EP2009/052810 WO2009112502A1 (en) 2008-03-13 2009-03-10 Agent for treating disease
EP09720958.9A EP2260057B1 (en) 2008-03-13 2009-03-10 Anti-CD4 antibody dosage regimen for treating autoimmune disease
BRPI0909179-3A BRPI0909179A2 (en) 2008-03-13 2009-03-10 Pharmaceutical composition and method of treatment of an autoimmune disease.
NZ602518A NZ602518A (en) 2008-03-13 2009-03-10 Agent for treating disease
RU2010141822/10A RU2540018C2 (en) 2008-03-13 2009-03-10 Agent for disease treatment
CA2717812A CA2717812A1 (en) 2008-03-13 2009-03-10 Agent for treating disease
ES09720958.9T ES2610327T3 (en) 2008-03-13 2009-03-10 Dosing regimen of anti-CD4 antibodies for the treatment of autoimmune diseases
AU2009224690A AU2009224690B2 (en) 2008-03-13 2009-03-10 Agent for treating disease
JP2010550182A JP5604311B2 (en) 2008-03-13 2009-03-10 Disease treatment agent
CN2009801173185A CN102027018A (en) 2008-03-13 2009-03-10 Agent for treating disease
KR1020107022912A KR20100135808A (en) 2008-03-13 2009-03-10 Agent for treating disease
SG2013034210A SG190627A1 (en) 2008-03-13 2009-03-10 Agent for treating disease
CN200980143326.7A CN102215867B (en) 2008-09-29 2009-08-31 Composition for treating disease
PCT/EP2009/061210 WO2010034590A1 (en) 2008-09-29 2009-08-31 Composition for treating disease
MX2011003335A MX2011003335A (en) 2008-09-29 2009-08-31 Composition for treating disease.
NZ603751A NZ603751A (en) 2008-09-29 2009-08-31 Composition for treating disease
ES09782400.7T ES2528419T3 (en) 2008-09-29 2009-08-31 Composition for the treatment of diseases
DK09782400.7T DK2341937T3 (en) 2008-09-29 2009-08-31 Composition for the treatment of a disease
SG2013070859A SG194362A1 (en) 2008-09-29 2009-08-31 Composition for treating disease
KR1020117009215A KR20110061630A (en) 2008-09-29 2009-08-31 Composition for treating disease
EP09782400.7A EP2341937B1 (en) 2008-09-29 2009-08-31 Composition for treating disease
SI200931140T SI2341937T1 (en) 2008-09-29 2009-08-31 Composition for treating disease
JP2011528278A JP2012504110A (en) 2008-09-29 2009-08-31 Disease treatment composition
PT97824007T PT2341937E (en) 2008-09-29 2009-08-31 Composition for treating disease
AU2009296078A AU2009296078B2 (en) 2008-09-29 2009-08-31 Composition for treating disease
RU2011117293/10A RU2531548C2 (en) 2008-09-29 2009-08-31 Composition for treating disease
BRPI0919489A BRPI0919489A2 (en) 2008-09-29 2009-08-31 composition, kit, methods of treating a rheumatic disease, and rheumatoid arthritis in a patient, agent capable of activating cd4 + cd25 + regulatory t cells and methotrexate, and use of an agent capable of activating cd4 + cd25 + regulatory t cells and methotrexate
CA2738598A CA2738598C (en) 2008-09-29 2009-08-31 Composition for treating disease
PL09782400T PL2341937T3 (en) 2008-09-29 2009-08-31 Composition for treating disease
IL207892A IL207892A0 (en) 2008-03-13 2010-08-31 Agent for treating disease
US12/880,768 US9550831B2 (en) 2008-03-13 2010-09-13 Method for treating psoriasis
CR11723A CR11723A (en) 2008-03-13 2010-10-11 AGENT TO TREAT DISEASE
CO10127116A CO6311008A2 (en) 2008-03-13 2010-10-13 PHARMACEUTICAL COMPOSITION UNDERSTANDING AN AGENT THAT ACTIVATES REGULATORY T-CELLS CD4 + CD25 +
IL211904A IL211904A (en) 2008-09-29 2011-03-24 Kit and compositions comprising methotrexate and anti-cd4 antibody for the treatment of rheumatic disease
US13/074,357 US20110229465A1 (en) 2008-09-29 2011-03-29 Composition for treating disease
CO11050626A CO6361951A2 (en) 2008-09-29 2011-04-26 COMPOSITION TO TREAT DISEASES
CR20110226A CR20110226A (en) 2008-09-29 2011-04-29 COMPOSITION TO TREAT DISEASE
HK11109118.5A HK1154797A1 (en) 2008-09-29 2011-08-29 Composition for treating disease
JP2014011246A JP2014101369A (en) 2008-03-13 2014-01-24 Agent for treating disease
HRP20150238AT HRP20150238T1 (en) 2008-09-29 2015-03-02 Composition for treating disease
JP2015097888A JP6154847B2 (en) 2008-09-29 2015-05-13 Disease treatment composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0817809A GB0817809D0 (en) 2008-09-29 2008-09-29 Agent for treating disease

Publications (1)

Publication Number Publication Date
GB0817809D0 true GB0817809D0 (en) 2008-11-05

Family

ID=40019735

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0817809A Ceased GB0817809D0 (en) 2008-03-13 2008-09-29 Agent for treating disease

Country Status (1)

Country Link
GB (1) GB0817809D0 (en)

Similar Documents

Publication Publication Date Title
IL207892A0 (en) Agent for treating disease
HK1151533A1 (en) Agent for treating disease
ZA201007215B (en) Agent for treating disease
EP2322076A4 (en) Treating endoscope
EP2252148A4 (en) Methods for treating bowel diseases
IL209895A0 (en) Compounds for treating beta-amyloidoses
IL213619A0 (en) Treatment
GB0802116D0 (en) Treatment
EP2365747A4 (en) Methods for treating gastrointestinal diseases
EP2338519A4 (en) Agent for treating myelofibrosis
EP2282826A4 (en) Methods for treating odors
GB0822011D0 (en) Treatment
EP2341936A4 (en) METHODS FOR TREATING OR PREVENTING IL-1ß RELATED DISEASES
ZA201204845B (en) Agents for treating disease
GB0811992D0 (en) Treatment
HK1154797A1 (en) Composition for treating disease
ZA201009226B (en) Nifurtimox for treating disease caused by trichomonadida
EP2517698A4 (en) Agent for treating parkinson's disease
EP2240192A4 (en) Treatment for dermatological conditions
GB0820972D0 (en) Treatment
GB0805912D0 (en) Treatment
EP2210878A4 (en) Therapeutic agent for trpv1-mediated disease
GB0817809D0 (en) Agent for treating disease
GB0817811D0 (en) Agent for treating disease
GB0817810D0 (en) Agent for treating disease

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)